Viking Therapeutics VKTX
NASDAQ VKTX
$25.83 -0.55 (-2.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Net Equity Issued and Repurchased (2014 - 2026)

Updated

Viking Therapeutics (VKTX) recorded Net Equity Issued and Repurchased of $1 million in Q2 2026, up 81.5% from $551,000 a year earlier and up 100.0% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends

On a TTM basis, Viking Therapeutics' Net Equity Issued and Repurchased came in at $2.6 million as of Jun 30, 2026, down 35.0% year-over-year; for FY2025, it came in at $2 million, down 80.8% from FY2024.

  • Across earlier years, Net Equity Issued and Repurchased came in at $10.4 million in FY2024 (+62.5%) and $6.4 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Net Equity Issued and Repurchased since Q3 2024.
  • On a year-over-year basis, Net Equity Issued and Repurchased has increased for three consecutive quarters, with an average decline of 19.7% over the last six quarters.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 81.5% in Q2 2026, against a decline of 92.0% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $500,000 (Q1 2026), $664,000 (Q4 2025) and $436,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Viking Therapeutics 2.99 Bn 464.96 Mn - 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 500,000.00
Dec 31, 2025 3.16 Mn
Sep 30, 2025 436,000.00
Jun 30, 2025 551,000.00
Mar 31, 2025 349,000.00
Dec 31, 2024 11.40 Mn
Sep 30, 2024 2.51 Mn
Jun 30, 2024 2.94 Mn
Mar 31, 2024 4.36 Mn
Dec 31, 2023 6.57 Mn
Jun 30, 2023 2.60 Mn
Mar 31, 2023 4.00 Mn
Dec 31, 2022 150,000.00
Jun 30, 2022 -1.59 Mn
Mar 31, 2022 -4.51 Mn
Dec 31, 2021 66,000.00
Sep 30, 2021 5,000.00
Jun 30, 2021 1.90 Mn
Mar 31, 2021 5.66 Mn
API Access

Viking Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VKTX&period=max&api_key=YOUR_API_KEY